Playing by protocol

Read more

Novartis receives positive opinion from CHMP for Lucentis

Read more

Stem cell study could aid quest to combat range of diseases

Read more

Value-added OTCs on the radar

Read more

‘The import tax anomalies faced by MD manufacturers, are ‘tariff barriers’ erected against domestic companies’

Read more

DoP calls for comments on soft loan scheme for mid-sized pharma cos

Read more

Cipla expands collaboration with Meda in allergic rhinitis segment

Read more

Quest Life Sciences to tap US market

Read more

Zydus pioneers India’s first NCE, introduces Lipaglyn

Read more

Sun Pharma announces US FDA approval for generic depo-testosterone injection

Read more